Non-adherence to Immunosuppressives in Kidney Transplantation in Brazil Multicenter Study
NCT02066935 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1105
Last updated 2019-02-15
Summary
The purpose of the study are: 1. To estimate the prevalence of non-adherence to immunosuppressants, and to other treatment-related aspects (smoking cessation, alcohol consumption, physical activity, and appointment keeping), in KT recipients among different KT centres across different regions of Brazil; 2. To explore multilevel factors associated to immunosuppressive adherence at the level of patient (socio-demographic, clinical), healthcare provider (patient satisfaction with the interpersonal dimension of care, trust in the transplant team, social support), healthcare organization (composition of the team, operational access, CIM transplant program practice patterns), and healthcare system and policies (perceived financial burden of the treatment regimen, insurance status, barriers to access to the immunosuppressive drugs, Brazilian region);
Conditions
- Medication Adherence
Interventions
- OTHER
-
kidney transplant patient
kidney transplanted patients for at least one year
Sponsors & Collaborators
-
Hospital das Clínicas de São Paulo - SP
collaborator UNKNOWN -
Instituto de Urologia e Nefrologia - São José Rio Preto/SP
collaborator UNKNOWN -
Hospital do Rim/UNIFESP - SP
collaborator UNKNOWN -
Hospital Israelita Albert Einstein
collaborator OTHER -
Hospital de Clinicas da Unicamp - SP
collaborator UNKNOWN -
Hospital São Francisco de Assis na Providência de Deus - RJ
collaborator UNKNOWN -
Hospital Universitário UFJF - MG
collaborator UNKNOWN -
Santa Casa de Juiz de Fora - MG
collaborator UNKNOWN -
Fundação Prorim Hospital Municipal de São José Joinvile - SC
collaborator UNKNOWN -
Santa Casa de Porto Alegre - RS
collaborator UNKNOWN -
Hospital das Clínicas de Porto Alegre - RS
collaborator UNKNOWN -
Hospital e Maternidade Angelina Caron - SC
collaborator UNKNOWN -
Hospital Universitário do Maranhão - MA
collaborator UNKNOWN -
Hospital Walter Cantidio - CE
collaborator UNKNOWN -
Hospital Ofir Loyola - PA
collaborator UNKNOWN -
Santa Casa de Misericórdia de Belo Horizonte - MG
collaborator UNKNOWN -
Hospital São João de Deus - Divinolopis-MG
collaborator UNKNOWN -
Hospital Antonio Targino- PB
collaborator UNKNOWN -
University of Brasilia
collaborator OTHER -
Hospital Onofre Lopes - RN
collaborator UNKNOWN -
Fundação Instituto Mineiro de Estudo Pesquisa Em Nefrologi
lead OTHER
Principal Investigators
-
HELADY S PINHEIRO, MD, PhD · Fundação Instituto Mineiro de Estudos e Pesquisas em Nefrologia
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2017-09-30
- Completion
- 2017-09-30
Countries
- Brazil
Study Locations
More Related Trials
-
Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients
NCT02426502 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Mycophenolate-Based Therapy for Kidney Transplant Recipients Without HLA-DQ Mismatch
NCT06493526 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients
NCT02453867 ·Status: UNKNOWN ·Phase: PHASE4
-
Protective Immunity Project 01
NCT00788021 ·Status: COMPLETED
-
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
NCT01363752 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function
NCT02334488 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Desensitization Protocols in HLA-incompatible Kidney-transplant Candidates
NCT03507348 ·Status: TERMINATED ·Phase: NA
-
Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen
NCT01560572 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After Kidney Transplantation in Adults
NCT01455649 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Mycophenolate Mofetil and Cyclosporin, Without Concomitant Corticosteroids, After a First Renal Transplant
NCT00200551 ·Status: COMPLETED ·Phase: PHASE4
-
Renal Transplantation in the Elderly - nEverOld Study
NCT01631058 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure
NCT06676696 ·Status: RECRUITING ·Phase: PHASE4
-
Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients
NCT02683291 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients.
NCT00758602 ·Status: COMPLETED ·Phase: PHASE4
-
Adherence to Immunosuppressive Therapy Liver Transplant Recipients
NCT01959308 ·Status: UNKNOWN
-
The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.
NCT00275522 ·Status: COMPLETED ·Phase: PHASE4
-
Immunosuppressant Medication Dosed Daily After Kidney Transplant
NCT04156204 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
European Transplant Registry of Senior Renal Transplant Recipients on Advagraf
NCT02558452 ·Status: NOT_YET_RECRUITING
-
Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.
NCT00296309 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of mDOT for Immunosuppressant Adherence in Solid Organ Transplant Recipients
NCT04587024 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection
NCT01353053 ·Status: UNKNOWN
-
Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR
NCT02581436 ·Status: COMPLETED ·Phase: NA
-
Improved Induction and Maintenance Immunosuppression in Kidney Transplantation
NCT00556933 ·Status: COMPLETED ·Phase: PHASE4
-
Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation
NCT03292445 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal Transplant
NCT02251691 ·Status: UNKNOWN ·Phase: PHASE4